CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1-2 Trial for Patients With Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT With a T-cell Depleted Graft With Infusion of Conventional T-cells and Regulatory T-cells

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01660607
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:25.701137+00:00
Published At: 2025-08-19T00:00:00+00:00
Record Updated At: 2025-08-19
Results Posted At: 2025-08-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Myeloid Leukemia, Chronic", "Acute Myelogenous Leukemia", "Myelodysplastic Syndromes (MDS)", "Lymphoma, Non-Hodgkin", "Acute Lymphoblastic Leukemia (ALL)", "Myeloproliferative Syndrome", "Acute Myeloid Leukemia", "Acute Leukemia", "Chronic Myelogenous Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-19"
protocolSection.identificationModule.nctId: "NCT01660607"
protocolSection.identificationModule.officialTitle: "Phase 1-2 Trial for Patients With Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT With a T-cell Depleted Graft With Infusion of Conventional T-cells and Regulatory T-cells"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-08-19"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.